0001950047-23-001247.txt : 20230602 0001950047-23-001247.hdr.sgml : 20230602 20230602173454 ACCESSION NUMBER: 0001950047-23-001247 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230602 DATE AS OF CHANGE: 20230602 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 23990372 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Schilke Tobin CENTRAL INDEX KEY: 0001678984 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT, #371 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001678984 XXXXXXXX LIVE 0001479290 REVANCE THERAPEUTICS, INC. 001-36297 1222 Demonbreun Street, Suite 2000 Nashville TN 37203 (615) 724-7755 TOBIN SCHILKE Officer Common E*TRADE FINANCIAL CORPORATION

3 EDISON DRIVE ALPHARETTA GA 30005

500 15500.00 84040352 06/02/2023 NASD COMMON 02/15/2021 Restricted Stock ISSUER N 500 02/15/2021 Not Applicable N TOBIN SCHILKE

1222 Demonbreun Street, Suite 2000 Nashville TN 37203

Common 06/01/2023 2701 82569.57 TOBIN SCHILKE

1222 Demonbreun Street, Suite 2000 Nashville TN 37203

common 05/15/2023 21401 738674.00 TOBIN SCHILKE

1222 Demonbreun Street, Suite 2000 Nashville TN 37203

Common 05/01/2023 3201 101471.70 TOBIN SCHILKE

1222 Demonbreun Street, Suite 2000 Nashville TN 37203

common 04/03/2023 3201 102719.00 TOBIN SCHILKE

1222 Demonbreun Street, Suite 2000 Nashville TN 37203

common 03/09/2023 18517 584303.00 06/02/2023 11/18/2022 /s/ Tobin C Schilke